NCT03126214CompletedPhase 4
Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing
Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing: Program for the Identification of 'Actionable' AF (PIAAF) Rx Study
Source: ClinicalTrials.gov · Last updated 5 Jan 2024
Brief summary (registry, in English)
The purpose of this study is to compare the effectiveness of prescribing oral anticoagulation therapy by pharmacist intervention compared to enhanced usual care in participants with unrecognized AF and/or known AF but not taking blood thinners.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 79 (actual)
- First submitted
- 12 Apr 2017
- Start date
- 1 Feb 2018
- Primary completion date
- 1 Jul 2022
- Lead sponsor
- University of Alberta
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT03126214
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 79
- From 1 Feb 2018 to the primary completion date, 1 Jul 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Uncontrolled hypertension (defined as average SBP ≥ 160 mmHg \[2 readings taken at time of screening\]).
- End stage renal disease (CrCl \< 15 ml/min)
- Valvular Heart Disease including those with prosthetic valve, mitral stenosis (moderate to severe) or valve repair.
- History of "Major Bleeding" at any point (defined as overt bleeding at a critical site including intracranial, intraspinal, intraocular, pericardial, or retroperitoneal; or bleed requiring hospitalization).
- Severe cognitive impairment (defined as score ≥ 5 on the Short Portable Mental Status Questionnaire)
Other
- Excess alcohol intake (males: ≥ 28 units/week, females: ≥ 21 units/week. One unit of alcohol = 8 oz beer, 1 oz hard liquor or 4 oz wine).
- Intracranial bleed at any point.
- Foreshortened life-expectancy or severe comorbidities precluding study follow-up period
- Unable to read/understand English
Who the study is looking for
- Age ≥ 65 years with one additional stroke risk factor (hypertension, diabetes, heart failure history of or left ventricular ejection fraction \<0.40), previous stroke or transient ischemic attack).
- Atrial fibrillation and not on oral anticoagulation (OAC) therapy but eligible
- Atrial fibrillation on sub-optimal OAC
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alberta Coordinator of this site? Confirm its status | Edmonton | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.